Mesenchymal Stem Cells from Wharton's Jelly and Amniotic Fluid
- 1 February 2016
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Obstetrics & Gynaecology
- Vol. 31, 30-44
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Human Mid-Trimester Amniotic Fluid Stem Cells Cultured Under Embryonic Stem Cell Conditions with Valproic Acid Acquire Pluripotent CharacteristicsStem Cells and Development, 2012
- Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free ApproachMolecular Therapy, 2012
- Isolation of human mesenchymal stem cells from third‐trimester amniotic fluidInternational Journal of Gynecology & Obstetrics, 2008
- Immunoregulatory function of mesenchymal stem cellsEuropean Journal of Immunology, 2006
- Mesenchymal Stem Cells in the Wharton's Jelly of the Human Umbilical CordStem Cells, 2004
- Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantationBlood, 2003
- Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?Human Reproduction, 2003
- Fetal Tissue Engineering from Amniotic FluidJournal of the American College of Surgeons, 2003
- Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based TherapiesTissue Engineering, 2001
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999